A detailed history of Entry Point Capital, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 630 shares of ILMN stock, worth $73,262. This represents 0.08% of its overall portfolio holdings.

Number of Shares
630
Previous 1,573 59.95%
Holding current value
$73,262
Previous $219 Million 60.5%
% of portfolio
0.08%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $120,449 - $138,809
-943 Reduced 59.95%
630 $86.5 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $145,958 - $224,199
1,573 New
1,573 $219 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $18.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.